As of January 2025, Celltrion Pharm has a market cap of $1.77B. This makes Celltrion Pharm the world's 5474th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $2.92B | 11.50% |
2023 | $2.62B | 44.71% |
2022 | $1.81B | -43.53% |
2021 | $3.20B | -46.30% |
2020 | $5.97B | 511.49% |
2019 | $975.80M | -34.19% |
2018 | $1.48B | 3.76% |
2017 | $1.43B | 161.19% |
2016 | $547.12M | 42.59% |
2015 | $383.72M | 98.12% |
2014 | $193.68M | -7.62% |
2013 | $209.65M | -49.70% |
2012 | $416.80M | - |